Assembly of Topic Knowledgeable Committee (SEC) of the Central Medicine Normal Management Organisation (CDSCO) will probably be held on Wednesday to deliberate on emergency use authorisation software of Russian vaccine Sputnik V.
The vaccine producers in India, Dr Reddy’s, have already submitted the security and immunogenicity knowledge of the third section trials.
On Tuesday, Union Well being Minister Harsh Vardhan had stated seven extra COVID-19 vaccine candidates are in phases of medical trials. He made the assertion after receiving the second dose of the COVID-19 vaccine at Delhi Coronary heart and Lung Institute.
Harsh Vardhan had stated, “Round seven extra COVID vaccine candidates are in medical trials. A few of them are within the superior section of the trials. Round two dozen vaccines are in pre-clinical trials.”
In September 2020, Dr Reddy’s partnered with the Russian Direct Funding Fund (RDIF) to conduct medical trials of Sputnik V and for its distribution rights in India.
The vaccine developed by the Gamaleya Nationwide Analysis Institute of Epidemiology and Microbiology was registered by the Ministry of Well being of Russia on August 11 final yr. India already has two accepted COVID-19 vaccines — Covaxin and Covishield — which can be presently being administered to the general public.
(With ANi inputs)